Hanan R. H. Mohamed

Cobalt oxide nanoparticles disrupt cellular homeostasis through oxidative genomic instability and mitochondrial stress, driving necrosis in non-small lung cancer cells

Non–small cell lung cancer (NSCLC) remains one of the most aggressive and treatment-resistant malignancies worldwide, with current therapies often limited by poor tumor specificity, resistance, and systemic toxicity. Nanoparticle-based therapeutics offer a promising strategy to overcome these challenges. Cobalt oxide n...